» Articles » PMID: 29154808

Genetic Host Factors in Helicobacter Pylori-induced Carcinogenesis: Emerging New Paradigms

Overview
Publisher Elsevier
Date 2017 Nov 21
PMID 29154808
Citations 38
Authors
Affiliations
Soon will be listed here.
Abstract

Helicobacter Pylori is a gram negative rod shaped microaerophilic bacterium that colonizes the stomach of approximately half the world's population. Infection with c may cause chronic gastritis which via a quite well described process known as Correas cascade can progress through sequential development of atrophic gastritis, intestinal metaplasia and dysplasia to gastric cancer. H. pylori is currently the only bacterium that is classified as a class 1 carcinogen by the WHO, although the exact mechanisms by which this bacterium contributes to gastric carcinogenesis are still poorly understood. Only a minority of H. pylori-infected patients will eventually develop gastric cancer, suggesting that host factors may be important in determining the outcome of H. pylori infection. This is supported by a growing body of evidence suggesting that the host genetic background contributes to risk of H. pylori infection and gastric carcinogenesis. In particular single nucleotide polymorphisms in genes that influence bacterial handling via pattern recognition receptors appear to be involved, further strengthening the link between host risk factors, H. pylori incidence and cancer. Many of these genes influence cellular pathways leading to inflammatory signaling, inflammasome formation and autophagy. In this review we summarize known carcinogenic effects of H. pylori, and discuss recent findings that implicate host genetic pattern recognition pathways in the development of gastric cancer and their relation with H. pylori.

Citing Articles

The Challenges of Treating a Infection following the COVID-19 Pandemic in Croatia: A Review.

Jukic I, Vukovic J J Clin Med. 2024; 13(19).

PMID: 39407822 PMC: 11477188. DOI: 10.3390/jcm13195762.


Association between and its eradication and the development of cancer.

Loosen S, Mertens A, Klein I, Leyh C, Krieg S, Kandler J BMJ Open Gastroenterol. 2024; 11(1).

PMID: 39181567 PMC: 11344509. DOI: 10.1136/bmjgast-2024-001377.


Programmed cell death in infection and related gastric cancer.

Lin Y, Liu K, Lu F, Zhai C, Cheng F Front Cell Infect Microbiol. 2024; 14:1416819.

PMID: 39145306 PMC: 11322058. DOI: 10.3389/fcimb.2024.1416819.


Mutations in Helicobacter pylori infected patients with chronic gastritis, intestinal type of gastric cancer and familial gastric cancer.

Hnatyszyn A, Szalata M, Zielinska A, Wielgus K, Danielewski M, Hnatyszyn P Hered Cancer Clin Pract. 2024; 22(1):9.

PMID: 38867324 PMC: 11167877. DOI: 10.1186/s13053-024-00282-8.


Interplay of homologous-recombination genes and in gastric cancer susceptibility.

Bueno Lemos F, de Melo F Transl Cancer Res. 2023; 12(11):2984-2988.

PMID: 38130304 PMC: 10731346. DOI: 10.21037/tcr-23-1570.